These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 29751486)

  • 1. Current Strategies for Inhibition of Chikungunya Infection.
    Subudhi BB; Chattopadhyay S; Mishra P; Kumar A
    Viruses; 2018 May; 10(5):. PubMed ID: 29751486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
    Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivirals against the Chikungunya Virus.
    Battisti V; Urban E; Langer T
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
    Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
    Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Members of the
    Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapeutics for chikungunya virus.
    Ghildiyal R; Gabrani R
    Expert Opin Ther Pat; 2020 Jun; 30(6):467-480. PubMed ID: 32249636
    [No Abstract]   [Full Text] [Related]  

  • 9. 4'-Fluorouridine inhibits alphavirus replication and infection
    Yin P; May NA; Lello LS; Fayed A; Parks MG; Drobish AM; Wang S; Andrews M; Sticher Z; Kolykhalov AA; Natchus MG; Painter GR; Merits A; Kielian M; Morrison TE
    mBio; 2024 Jun; 15(6):e0042024. PubMed ID: 38700353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chikungunya virus drug discovery: still a long way to go?
    Pérez-Pérez MJ; Delang L; Ng LFP; Priego EM
    Expert Opin Drug Discov; 2019 Sep; 14(9):855-866. PubMed ID: 31177861
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Strategies Against Chikungunya Virus.
    Abdelnabi R; Neyts J; Delang L
    Methods Mol Biol; 2016; 1426():243-53. PubMed ID: 27233277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of andrographolide against chikungunya virus infection.
    Wintachai P; Kaur P; Lee RC; Ramphan S; Kuadkitkan A; Wikan N; Ubol S; Roytrakul S; Chu JJ; Smith DR
    Sci Rep; 2015 Sep; 5():14179. PubMed ID: 26384169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antivirals against Chikungunya Virus: Is the Solution in Nature?
    Martins DOS; Santos IA; de Oliveira DM; Grosche VR; Jardim ACG
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32121393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
    Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
    J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.
    Langsjoen RM; Auguste AJ; Rossi SL; Roundy CM; Penate HN; Kastis M; Schnizlein MK; Le KC; Haller SL; Chen R; Watowich SJ; Weaver SC
    Antiviral Res; 2017 Jul; 143():246-251. PubMed ID: 28461071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of nobiletin against chikungunya virus in vitro.
    Lin SC; Chen MC; Li S; Lin CC; Wang TT
    Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chikungunya virus infections: time to act, time to treat.
    Abdelnabi R; Neyts J; Delang L
    Curr Opin Virol; 2017 Jun; 24():25-30. PubMed ID: 28414993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Highly Selective Antivirals for Chikungunya Virus identified from the Screening of a Drug-Like Compound Library.
    Castro EF; Álvarez DE
    Curr Microbiol; 2024 Sep; 81(10):343. PubMed ID: 39227496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.